Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 860.00, up by 2.85 points or 0.33% from its previous closing of Rs. 857.15 on the BSE.

The scrip opened at Rs. 858.00 and has touched a high and low of Rs. 864.90 and Rs. 855.40 respectively. So far 46172 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.70 on 07-Apr-2015 and a 52 week low of Rs. 748.15 on 26-Sep-2014.

Last one week high and low of the scrip stood at Rs. 864.90 and Rs. 824.70 respectively. The current market cap of the company is Rs. 207452.00 crore.

The promoters holding in the company stood at 54.71% while Institutions and Non-Institutions held 31.51% and 13.78% respectively.

In bid to expand its basket of specialty products to boost sales, Sun Pharmaceutical has bid to acquire US based eye care company InSite Vision Inc. The pact may be valued at around Rs 300 crore.

Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. The company provides high quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries worldwide.